Healthcare -
Biotechnology - NASDAQ - US
$ 7.72
-4.1 %
$ 5.38 M
Market Cap
0.0
P/E
RNAZ - TOTAL EQUITY
Total Equity RNAZ - TransCode Therapeutics, Inc.
1.64 M
LAST VALUE
-71.64%
2 YEAR CAGR
39.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR